Arkolith/Insider Trading/ZNTL/Form 4

Gallagher Cam

President, DirectorZentalis Pharmaceuticals, Inc. (ZNTL) · full profile →Form 4 · filed May 31, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$730K
Net Open-Market Flow
-$730K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 31, 2023Sell(S)9K$26.40$244K482K
May 31, 2023Sell(S)19K$26.21$486K464K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001725160-23-000125) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for Zentalis Pharmaceuticals, Inc.

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.

Form 4 insider API

Open-market buys and sells, cluster scans, company flows.

insider.transactions

13F holdings API

Owners, holdings, deltas, point-in-time portfolios.

stock.owners

MCP quickstart

Connect an agent, mint a key, make the first call.

/api/mcp